The members of the DT program share the scientific goals of examining the processes underlying cancer therapeutics, identifying molecular targets, determining how the molecular genetic profiles of tumors govern sensitivity to agents and combinations of agents, particularly targeted agents, and translating these findings into the design and implementation of novel therapeutic strategies for the tre